Dr. Hong He, MD., PhD, is a senior research fellow of the Department of Surgery, University of Melbourne. Dr. He has a broad background in biomedical sciences, with specific expertise in cancer biology, molecular mechanisms, and targeted therapy. Dr. He is among the pioneers in identifying, developing, and testing kinase inhibitors in cancer settings. Dr. He has broad collaboration with clinicians and scientists nationally and internationally. Dr. He has also initiated and conducted a couple of industry collaborations in developing and testing novel kinase inhibitors. Dr. He is a lead investigator on many research projects focusing on developing new therapeutic regimes for the treatment of cancer. Together with a surgeon-scientist, Dr. He has established the Pancreatic Cancer Biology Laboratory and has led a research team working on projects to identify potential targets in pancreatic cancer for its prevention and treatment. Dr. He's achievements in the establishment of unique mouse models, building up collaborations, and publication and presentation of the research papers have significantly increased the research impact. The results from one of the recent industry collaborations have won an international award.